Clinical trial · Observational
Venous Thromboembolic Complications in Ovarian Cancer
Venous Thromboembolic Complications in Patients With Ovarian Cancer Compared to Patients With Benign Ovarian Tumours
NCT02480790CI-TRIAL-00035165unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Objectives of the study are: To estimate the incidence of venous thromboembolism (VTE) in a cohort of women with suspected ovarian cancer and evaluate changes in the coagulation system in case of benign or malignant disease. The impact of changes in the coagulation system on disease prognosis will be evaluated.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Deep Vein Thrombosis | — | UNRESOLVED | — |
| Lung Embolism | — | UNRESOLVED | — |
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Ovarian Neoplasms | Ovarian Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Venous Thromboembolism | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Patients with malignant disease
- description
- Patients with ovarian, tubar or primary peritoneal cancer
- label
- Patients with benign disease
- description
- Patients with suspected ovarian cancer where the final pathologic diagnosis is benign
Primary outcomes (1)
- measure
- Venous thromboembolism due to ovarian cancer
- timeFrame
- one year
- description
- Compressive ultrasound scan of lower extremities and pulmonary CT-angiography
Secondary outcomes (2)
- measure
- Changes in the coagulation system in case of ovarian cancer
- timeFrame
- one year
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: Women referred to the Department of Gynaecology and Obstetrics, Aalborg University Hospital on suspicion of ovarian cancer can be included if they present with a RMI ≥ 200. Exclusion Criteria: 1. Previous cancer (within previous 3 years) or concomitant cancer of any origin. 2. Known immunological connective tissue disease. 3. Treatment with heparin, low molecular weight heparin (LMWH) or vitamin K antagonist at the time of inclusion. 4. Lack of informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.